h3 mrna / lnp vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 12, 2023 (NCT05829356)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07053072 | Phase 1/Phase 2 (Phase 2) | Jul 15, 2025 | Sichuan University |
| NCT05829356 | Phase 1 | Apr 12, 2023 | Sanofi-Aventis |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sanofi-Aventis | For profit | 1 | 1 | 1 | 2023 |
| Sichuan University | Academic/Hospital | 1 | 1 | 1 | 2025 |
2 organizations
Page 1 / 1